# Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

> **NCT00909129** · NA · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 25 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Chronic Hepatitis C

## Interventions

- **DRUG:** pegylated interferon-alpha (Pegasys)
- **DRUG:** ribavirin (COPEGUS)

## Key facts

- **NCT ID:** NCT00909129
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2009-05-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909129, "Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00909129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*